Replies to post #26660 on Cytogenix (fka CYGX)

[bigworld]

JJ: Indeed, it was an excellent call. It is clear to me that management was holding back on lots of information until the Phanuel Pursuits litigation was behind them. This is not a stock to trade in and out of at this time. Who knows what else is up Malcolm's sleeve. They have so much out-sourced research going on, and I think it is only going to be a matter of a few weeks before we hear how GE Healthcare or someone else is going to help them with funds to build out the entire synDNA production facility. As the good results from synDNA vaccine testing comes in, it is clear that they have to ramp up their production capabilities if they want to fully exploit their window of opportunity. CYGX is firing on all cylinders and I feel bad for those folks who did not or could not obtain a meaningful position in this stock. To expect a retreat back to the 80's or even the 90's might be unrealistic at this point, especially if the PR parade continues. Happy New Year to you and all the loyal CYGX shareholders!!!